(Q40927868)

24 September 2017

1 reference

title

Metformin and intestinal glucose handling (English)

1 reference

24 September 2017

1 reference

Bailey CJ

1

1 reference

24 September 2017

publication date

1 September 1995

1 reference

Diabetes/metabolism reviews

24 September 2017

published in

1 reference

24 September 2017

volume

11 Suppl 1

1 reference

24 September 2017

page(s)

S23-32

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

24 September 2017

1 reference

Reconsideration of inhibitory effect of metformin on intestinal glucose absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Effect of metformin on glucose metabolism in the splanchnic bed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Importance of the intestine as a site of metformin-stimulated glucose utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Metformin kinetics in healthy subjects and in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Disposition of metformin (N,N-dimethylbiguanide) in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Subcellular distribution of metformin in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Glucose absorption from the rat jejunum during acute exposure to metformin and phenformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Insulin requirement for the antihyperglycaemic effect of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

Polypeptide hormone receptors in vivo: demonstration of insulin binding to adrenal gland and gastrointestinal epithelium by quantitative radioautography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

The acute regulation of glucose absorption, transport and metabolism in rat small intestine by insulin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Sites of metformin-stimulated glucose metabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Metformin in the digestive tract

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Pharmacokinetics of metformin after intravenous and oral administration to man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Accumulation of metformin by tissues of the normal and diabetic mouse

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Guanidines and biguanides

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Analysis of the inhibitory effect of biguanides on glucose absorption: Inhibition of active sugar transport

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

The biguanide inhibition of d-glucose transport in membrane vesicles from small intestinal brush borders

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Mechanism of metformin action in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

The effect of metformin on glycaemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Effect of chronic metformin treatment of hepatic and muscle glycogen metabolism in KK mice

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610110505

7 January 2021

Identifiers

DOI

10.1002/DMR.5610110505

1 reference

24 September 2017

1 reference